Physician

Daniel Blake Goldish, MD

According to 2025 Medicare claims, Daniel Goldish, MD (NPI: 1124413554) practices physical medicine and rehabilitation in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is STEINDLER ORTHOPEDIC CLINIC, PLC (NPI: 1942276621; TIN: 421436594) and primary practice location at 52317-7908.

Goldish's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 614 traditional Medicare patients, billed 11,627 HCPCS/CPT codes, and received $275,448 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 284 prescription claims across 108 beneficiaries totaling $3,681 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 8 records totaling $1,050. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $22,183 to $275,448. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $579 and ending at $3,681. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$138K$275K2020 Medicare payment: $22,183 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $217,334 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $237,865 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $258,156 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $275,448 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202067810$22,183
20215319,639$217,334
202261310,899$237,865
202362711,082$258,156
202461411,627$275,448

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.0K$14K2015 Drug cost: $579 (USD; Tot_Drug_Cst)2016 Drug cost: $2,355 (USD; Tot_Drug_Cst)2017 Drug cost: $1,361 (USD; Tot_Drug_Cst)2019 Drug cost: $6,244 (USD; Tot_Drug_Cst)2020 Drug cost: $1,054 (USD; Tot_Drug_Cst)2021 Drug cost: $7,370 (USD; Tot_Drug_Cst)2022 Drug cost: $14,035 (USD; Tot_Drug_Cst)2023 Drug cost: $13,808 (USD; Tot_Drug_Cst)2024 Drug cost: $3,681 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151225$579
20161371$2,355
20171450$1,361
2018N/RN/RN/R
2019N/R30$6,244
20202457$1,054
2021122412$7,370
2022177842$14,035
2023201833$13,808
2024108284$3,681

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
64483Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level241295$215
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more233380$94
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg1871,208$1
Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml244879$0
J1100Injection, dexamethasone sodium phosphate, 1 mg2614,370$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GabapentinGabapentin943,031$1,448
PregabalinPregabalin902,997$1,326
Duloxetine HclDuloxetine Hcl562,280$673
MeloxicamMeloxicam12360$27

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$1,050SI-BONE, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Blake Goldish, MD?

Tedicare shows public-source Medicare data for Daniel Blake Goldish, MD (NPI 1124413554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Blake Goldish, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Blake Goldish, MD?

Daniel Blake Goldish, MD is linked to STEINDLER ORTHOPEDIC CLINIC, PLC (billing NPI 1942276621) in the available physician profile data.

Does Daniel Blake Goldish, MD have Open Payments data?

Daniel Blake Goldish, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.